How Hormone Therapy Can Help — When It’s Done the Way the Body Actually Works

For the last two decades, “hormone replacement therapy” has carried a kind of built-in warning label in the popular imagination — thanks largely to the Women’s Health Initiative (WHI), the large 2002 study whose headline finding, “estrogen causes breast cancer,” reshaped medicine almost overnight. Within months, millions of women stopped their hormone therapy, on the advice of their physicians or on their own. Premarin, once the most prescribed drug in the world, became the drug most likely to be discontinued — and the one doctors became least willing to prescribe.

In Estrogen: A Girl’s Best Friend, Dr. James S. Nagel argues that this reaction, while understandable, came at a real cost, and was built on a study that gets misread far more often than it gets carefully understood. A Yale-led analysis cited in the book estimates that the resulting years of estrogen avoidance contributed to somewhere between 42,292 and 48,835 preventable deaths among women aged 50 to 69 between 2002 and 2012. Physicians who’ve gone back to reexamine the WHI data since — including Dr. Steven Goldstein at NYU and Dr. Leon Speroff, longtime author of the field’s leading textbook on reproductive endocrinology — have argued that the original findings were over-interpreted, and that the actual risks of hormone therapy, properly understood, are considerably smaller than the headlines suggested.

None of that means every form of hormone therapy is equivalent, or that the conversation about risk disappears. It means, in Nagel’s view, that the conversation needs to be far more specific than “hormones: yes or no.” The therapy used in the WHI — oral conjugated equine estrogen (Premarin, derived from pregnant mares’ urine) paired with synthetic progestins — isn’t the same thing as bio-identical hormone therapy administered the way the body actually produces it. That distinction is the entire subject of the book’s approach, which Nagel calls Rhythmic Bio-Identical Hormone Restoration Therapy, or RBHRT.

Three things that make restoration therapy different

Bio-identical, not synthetic. Estradiol is estradiol — chemically identical to what a woman’s own ovaries produce. A synthetic hormone, or an estrogen extracted from another species, doesn’t interact with the body’s receptors in quite the same way, and substituting it can throw a woman’s physiology further out of balance rather than restoring it.

Rhythmic, not static. This is the piece most conventional hormone therapy skips entirely. A healthy, reproductive-age woman’s estrogen isn’t a flat, constant level — it rises and falls in a wave-like pattern across roughly a 28-day cycle, climbing toward a mid-cycle peak before ovulation and receding afterward. Nagel’s argument is that dosing hormones as a flat daily amount, the way most HRT is prescribed, only ever approximates a fraction of what the body is actually built to run on. Rhythmic restoration instead varies the dose day by day to mimic that natural curve, tracked and adjusted cycle by cycle against bloodwork.

Transdermal, not oral. How a hormone enters the bloodstream turns out to matter enormously for safety. A large Danish study that followed 698,098 women found that when estrogen was delivered through the skin, the risk of heart attack dropped 38% compared to oral estrogen; delivered vaginally, it dropped 44%. Transdermal delivery was also associated with a meaningfully lower risk of blood clots than oral administration. Skipping the digestive system and the liver’s “first pass” appears to change the entire risk profile of the therapy.

What monitoring actually looks like

This isn’t a start-it-and-forget-it approach, and the book is emphatic that it shouldn’t be attempted outside the care of a physician trained specifically in hormone restoration. A proper workup involves a detailed personal and family history, followed by baseline bloodwork — estradiol, progesterone, FSH, LH, a full thyroid panel, testosterone, SHBG, vitamin D, a fasting lipid panel, and more — typically drawn on day 21 of the cycle. Dosing starts conservatively and is adjusted over three to six months based on lab results and how the patient is responding, with follow-up labs roughly every three to four cycles once levels stabilize. Women over 40 are advised to keep up with yearly mammograms; those with a uterus need pelvic ultrasound monitoring for any irregular bleeding. It’s a genuinely collaborative, iterative process between patient and physician — not a prescription refilled on autopilot.

What the payoff looks like

When it’s dialed in, the changes described in the book are substantial: more restorative sleep, more stable mood, sharper memory, a return of libido, migraines that resolve rather than get managed, cholesterol and blood pressure that improve, insulin resistance that eases. Patients profiled in the book describe it in less clinical terms. Paula S. describes rediscovering a level of desire and intimacy in her marriage she’d quietly given up on. Renee W., after a slow start, describes her migraines disappearing, her energy returning, and finally losing weight that had accumulated for years without explanation.

The bottom line

Dr. Nagel’s case isn’t that every woman needs hormone therapy, or that risk disappears the moment someone switches to a bio-identical, transdermal, rhythmic protocol. It’s that “hormone therapy” as a single, monolithic, feared category doesn’t hold up to scrutiny — the specifics of which hormone, delivered how, dosed on what schedule, and monitored by whom, matter enormously to both safety and results. As the book puts it in its closing pages, the goal isn’t just to alleviate a hot flash, but to replicate the full spectrum of what a healthy, hormonally balanced body is supposed to do.

If you’re considering hormone therapy, the conversation worth having with your physician isn’t “hormones or not” — it’s which kind, delivered how, and monitored how closely.

This piece summarizes the approach described in James S. Nagel, M.D.’s book, Estrogen: A Girl’s Best Friend. It is not medical advice. Hormone therapy carries real, individualized considerations — discuss your history and options with a qualified physician before making any changes to your care. SCHEDULE YOUR FREE CONSULTATION TODAY